NEWS

AstraZeneca uses genomics and proteomics software

AstraZeneca is using Cambridge Cell Network’s (CCnet) genomics and proteomics software ToxWiz to predict the effects of drugs used to treat liver disease.

The user-friendly approach provides a quick way to determine the relationships between side effects and specific proteins or pathways. The software allows researchers to search computational models of more than 500 biological pathways. Each pathway can then connect to a database of 800,000 abstracts.

Dr Scott Bayer, principal scientist and head of computational toxicology at AstraZeneca, said: ‘CCnet is listening in earnest to toxicologists, providing solutions to challenges we face and making appropriate software modifications as they are requested.’

Twitter icon
Google icon
Del.icio.us icon
Digg icon
LinkedIn icon
Reddit icon
e-mail icon
Feature

For functionality and security for externalised research, software providers have turned to the cloud, writes Sophia Ktori

Feature

Robert Roe investigates the growth in cloud technology which is being driven by scientific, engineering and HPC workflows through application specific hardware

Feature

Robert Roe learns that the NASA advanced supercomputing division (NAS) is optimising energy efficiency and water usage to maximise the facility’s potential to deliver computing services to its user community

Feature

Robert Roe investigates the use of technologies in HPC that could help shape the design of future supercomputers